Nemo Healthcare

safe births

healthy children

About Nemo

Nemo was founded in May 2010 as the result of joint research between Máxima Medical Center Veldhoven (MMC) and Eindhoven University of Technology (TU/e), both in the Netherlands. We focus on the improvement of fetal monitoring, based on electrophysiological signals, noninvasively recorded on the maternal abdomen.

Perinatal Research

The joint research between TU/e and MMC originates from the 1980's and has initially focused on analysis of hemodynamic signals of newborns in the Neonatal Intensive Care Unit (NICU). By applying advanced signal processing techniques, new insights have been obtained that have proven valuable for the diagnosis or treatment of sick newborns. In 2000, the research has expanded to the analysis of heart activity of the unborn child. This analysis aims at obtaining new information that can be used to improve fetal monitoring.

Electrophysiological Monitoring

In 2005, a project was started to develop methods for monitoring the condition of the unborn child by means of non-invasive electrophysiological recordings. This project was financed by the Dutch technology institute STW (Stichting Technische Wetenschappen, now part of Dutch Technology Foundation (NWO)). From these recordings, which are performed on the abdomen of a pregnant woman, information is obtained both on uterine activity and on fetal heart activity. The methods provide more accurate information than existing monitoring technologies and also provide unique information that other methods cannot provide. Additionally, the measurement method is more comfortable than existing alternatives and entirely free of risks for mother and child.

Clinical Applications

To fully exploit the potential of the new technology, the developed methods needed to be further developed into clinical applications. For this purpose, Nemo Healthcare was founded. With the help of two STW valorization grants, the technology for monitoring uterine activity was developed into a clinically applicable device (PUREtrace™). In 2011, a consortium of investors entered the company, providing the necessary funds for certification and commercialization of PUREtrace. At the same time, we started with the development of technology for measuring fetal heart activity. With a second investment round in 2016 and a EU Horizon 2020 SME (Small and Medium Sized Enterprises) Instrument phase 2 Grant, we are now finishing the development of our fetal monitoring technology, planned to be commercially available in the 2nd half of 2018.

Our team

Michiel Manuel

Michiel Manuel

Chief Executive Officer

I feel honored to lead and coach the focused, passionate and inspiring team of Nemo Healthcare in achieving our mission: Safe births, healthy children.
Will Ickenroth

Will Ickenroth

VP Business Development, Marketing & Sales

I am proud to work with a highly committed team of professionals that share the passion to develop innovative products, improving the quality of life of mother and child.
Chris Peters

Chris Peters

Chief Technology Officer, Medical Physicist, Founder

I am strongly committed to realize technology based solutions that contribute to a healthy future!
Rik Vullings

Rik Vullings

Chief Scientific Officer, Assistant Professor, Founder

I want to translate results of scientific research on pregnancy monitoring into tangible clinical applications that enable improvement of obstetrical care.
René Kok

René Kok

VP Medical Affairs, Gynaecologist

I feel privileged to help improve fetal monitoring to reduce neonatal mortality and morbidity rates.
Nenad Čabrilo

Nenad Čabrilo

Staff Engineer

I merge my passion for physiology and fitness with electrical engineering, to drive innovations in healthcare and human well being.
Harry Diakatos

Harry Diakatos

Senior Software Developer, Web Applications Architect

I feel so thrilled to apply my analytical skills and software expertise to help the advancement of care for mother and child.
Eleni Fotiadou

Eleni Fotiadou

Researcher

I am driven by my passion to develop and apply research to improve quality and efficiency in fetal monitoring.
Anne van der Linden

Anne van der Linden

Office Management & Communications

I am inspired being part of a highly motivated team, bringing pregnancy monitoring to a next level and contributing to improved diagnostics and better birth outcomes.
Rianne Peeters

Rianne Peeters

Office Management

In my opinion mother and child deserve the best care possible, that is why I enjoy working at Nemo Healthcare.
Joni Scholten

Joni Scholten

Engineer

I help create solutions to improve pregnancy care.
Mariël Schrijvers

Mariël Schrijvers

Quality Manager

I am thrilled about working for Nemo Healthcare, as it provides me with the opportunity to really make a difference in the lives of mothers and new-borns.
Marc-Antony Taminiau

Marc-Antony Taminiau

Marketing & Communication

I get our inspiring message, about qualitative fetal monitoring that helps both mother and child, across to our stakeholders globally.
Ralph Vroegop

Ralph Vroegop

Manager Business Development, Marketing & Sales

I am committed to make our Nemo solution, that contributes to the birth of healthy children, worldwide accessible.
Aron Wierts

Aron Wierts

Project leader

I have a strong drive to develop innovative solutions that bring fetal monitoring to the next level and make an impact on obstetric care for both mother and child.